Organization: Health Canada
Year: 2024
Month: April
Request Number: A-2023-001607
Request Summary: The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Semaglutide Abbreviated New Drug Submission (ANDS).
Disposition: No records exist
Number of pages: 0